Background/Aims: Slit ventricles and multiple episodes of shunt failure are problematic in many infants and preterm neonates shunted for hydrocephalus. We utilized ventriculosubgaleal (VSG) shunting as the initial neurosurgical intervention in neonates with hydrocephalus associated with intraventricular hemorrhage and infants with myelomeningocele. Methods: We conducted a chart review of 21 children initially treated with a VSG shunt between November 2002 and July 2009. Patient records and imaging studies were reviewed. Demographics, case data and clinical outcome were collected. Results: Five patients (27.8%) required a revision after conversion to a ventriculoperitoneal (VP) shunt. There were 9 cases of radiographic slit ventricles (45%). Average follow-up was 59.5 months (range 12–97 months). Average time interval to shunt conversion was 81.5 days. Two patients have not required conversion to a VP shunt (one with an 8-year follow-up). To date, none of these patients has required a subtemporal window or cranial vault expansion. Conclusion: Based on our results, initial management of selected hydrocephalic infants with a VSG shunt may prove to be advantageous in the long run for these children as the number of shunt revisions and the incidence of slit ventricles are significantly less than those reported in the literature.

Keywords:
Ventriculosubgaleal shunting, Shunt, Hydrocephalus, Slit ventricles, Revision
1.
National Institute of Neurological Disorders and Stroke: Hydrocephalus: Myths, New Facts, Clear Directions. Hydrocephalus: Myths, New Facts, Clear Directions, Bethesda, October, 2005.
2.
Choux M, DeRocco C, Hockley AD, Walker ML: Pediatric Neurosurgery. New York, Churchill Livingstone; 1999.
3.
Boynton BR, Boynton CA, Merritt TA, Vaucher YE, James HE, Bejar RF: Ventriculoperitoneal shunts in low birth weight infants with intracranial hemorrhage: neurodevelopmental outcome. Neurosurgery 1986;18:141–145.
4.
Gurtner P, Bass T, Gudeman SK, Penix JO, Philput CB, Schinco FP: Surgical management of posthemorrhagic hydrocephalus in 22 low-birth-weight infants. Childs Nerv Syst 1992;8:198–202.
5.
Kan P, Walker ML, Drake JM, Kestle JR: Predicting slit-like ventricles in children on the basis of baseline characteristics at the time of shunt insertion. J Neurosurg 2007;106 (suppl):347–349.
6.
Vinchon M, Lapeyre F, Duquennoy C, Dhellemmes P: Early treatment of posthemorrhagic hydrocephalus in low-birth-weight infants with valveless ventriculoperitoneal shunts. Pediatr Neurosurg 2001;35:299–304.
7.
Shooman D, Portess H, Sparrow O: A review of the current treatment methods for posthaemorrhagic hydrocephalus of infants. Cerebrospinal Fluid Res 2009;6:1.
8.
Fulmer BB, Grabb PA, Oakes WJ, Mapstone TB: Neonatal ventriculosubgaleal shunts. Neurosurgery 2000;47:80–83; discussion 83–84.
9.
Tansey FA, Zhang H, Cammer W: Expression of carbonic anhydrase II mRNA and protein in oligodendrocytes during toxic demyelination in the young adult mouse. Neurochem Res 1996;21:411–416.
10.
International randomised controlled trial of acetazolamide and furosemide in posthaemorrhagic ventricular dilatation in infancy. International PHVD Drug Trial Group. Lancet 1998;352:433–440.
11.
Libenson MH, Kaye EM, Rosman NP, Gilmore HE: Acetazolamide and furosemide for posthemorrhagic hydrocephalus of the newborn. Pediatr Neurol 1999;20:185–191.
12.
Levy ML, Masri LS, McComb JG: Outcome for preterm infants with germinal matrix hemorrhage and progressive hydrocephalus. Neurosurgery 1997;41:1111–1117; discussion 1117–1118.
13.
Marlin AE: Protection of the cortical mantle in premature infants with posthemorrhagic hydrocephalus. Neurosurgery 1980;7:464–468.
14.
McComb JG, Ramos AD, Platzker AC, Henderson DJ, Segall HD: Management of hydrocephalus secondary to intraventricular hemorrhage in the preterm infant with a subcutaneous ventricular catheter reservoir. Neurosurgery 1983;13:295–300.
15.
Davidoff LM: Treatment of hydrocephalus. Arch Surg 1929;18.
16.
Horsely JS: Surgical treatment of congenital hydrocephalus: Report of a case of meningocele and hydrocephalus. JAMA 1906;47.
17.
Dereymaeker A: De l’utilité du drainage ventriculaire préopératoire dans les tumeurs de la fosse postérieure chez l’enfant. Acta Neurol Psychiatr Belg 1948;48.
18.
Dogliotti A: Semplice procedimento per la derivazione sottocutanea del liquor ventriculare. Arch Ital Chir 1938;51.
19.
Ferreira N, Correa J: Derivacao liquorica ventriculo-subcutanea na terapeutica cirugica das fistulas liquoricas pos-operatorias rebeides. Neurobiologica 1972;35.
20.
Hoffman H: Ventriculosubgaleal shunt in the managment of recurrent ventriculoperitoneal shunt infection. Childs Nerv Syst 1994;10.
21.
Koljubakin S: Die operative Therapie der Hirnwassersucht. Arch Klin Chir Berlin 1924;128.
22.
Dardenne G: Treatment by subcutaneous ventricular drainage of refractory postoperative cerebrospinal fluid fistulas (in French). Acta Neurol Belg 1964;64:1202–1211.
23.
Fischer R: Surgery of the congenital anomalies; in Walker A (ed): A History of Neurological Surgery. New York, Hafner Publishing, 1967, pp 339–341.
24.
Savitz MH, Katz SS: Ventriculosubgaleal shunting for acute head trauma. Crit Care Med 1983;11:290–292.
25.
Schmid UD, Seiler RW: Management of obstructive hydrocephalus secondary to posterior fossa tumors by steroids and subcutaneous ventricular catheter reservoir. J Neurosurg 1986;65:649–653.
26.
Van Calenbergh F, Goffin J, Casaer P, Plets C: Use of a ventriculosubgaleal shunt in the management of hydrocephalus in children with posterior fossa tumors. Childs Nerv Syst 1996;12:34–37.
27.
Drapkin AJ, Levine ME, Yang WC: Ventriculo-subgaleal shunt: evaluation by computed tomography. Acta Neurochir (Wien) 1980;55:107–115.
28.
Sklar F, Adegbite A, Shapiro K, Miller K: Ventriculosubgaleal shunts: management of posthemorrhagic hydrocephalus in premature infants. Pediatr Neurosurg 1992;18:263–265.
29.
Rahman S, Teo C, Morris W, Lao D, Boop FA: Ventriculosubgaleal shunt: a treatment option for progressive posthemorrhagic hydrocephalus. Childs Nerv Syst 1995;11:650–654.
30.
Wellons JC, Shannon CN, Kulkarni AV, et al: A multicenter retrospective comparison of conversion from temporary to permanent cerebrospinal fluid diversion in very low birth weight infants with posthemorrhagic hydrocephalus. J Neurosurg Pediatr 2009;4:50–55.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.